| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.58B | -4.1% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥0.07B | — |
| Net income | ¥0.06B | +2.3% |
| Gross margin | 17.3% | Net margin 10.7% |
| Revenue Q/Q | -30.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.48B | 82.7% |
| R&D | ¥0.03B | 4.4% |
| SG&A | ¥0.02B | 4.3% |
| Tax & other | ¥0.01B | 1.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
英搏尔 ・ 朗新科技 ・ 海特生物 ・ 中石科技 ・ 艾德生物 ・ 智动力 ・ 赛意信息 ・ 创业黑马 ・ 澄天伟业 ・ 双一科技 ・ 联合光电 ・ 中赋科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies